FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943562300> ?p ?o ?g. }

• W2943562300 endingPage "e0216055" @default.
• W2943562300 startingPage "e0216055" @default.
• W2943562300 abstract "Introduction Neutrophils can generate extracellular net-like structures by releasing their DNA–histone complexes and antimicrobial peptides, which is called neutrophil extracellular traps (NETs). Various stimuli can induce NET formation. In particular, neutrophils and NET formation are abundant in tumor tissue. This study investigated how cancer cells induce NET formation and whether this NET formation promotes plasma thrombin generation and cancer progression. Methods Induction of NET formation by a pancreatic cancer cell line (AsPC-1) was assessed by measuring the histone–DNA complex level. The endogenous thrombin potential (ETP) was measured by thrombin generation assay. In vitro migration, invasion, and tubule formation assays were performed. The circulating levels of NET markers and hypercoagulability markers were assessed in 62 patients with pancreatobiliary malignancy and 30 healthy controls. Results AsPC-1 significantly induced NET formation in a dose-dependent manner. Conditioned medium (CM) from AsPC-1 also induced NETs. Interestingly, NET-formation was abolished by heat-inactivated CM, but not by lipid-extracted CM, suggesting an important role of protein components. A reactive oxygen species inhibitor did not inhibit cancer cell–induced NET formation, but prostaglandin E1 (PGE1, cyclic adenosine monophosphate inducer) and antithrombin did. NETs significantly increased ETP of normal plasma. Of note, NETs promoted cancer cell migration and invasion as well as angiogenesis, which were inhibited by histone-binding agents (heparin, polysialic acid), a DNA-degrading enzyme, and Toll-like receptor neutralizing antibodies. In patients with pancreatobiliary malignancy, elevated NET markers correlated well with hypercoagulability makers. Conclusion Our findings indicate that cancer cell–induced NET formation enhances both hypercoagulability and cancer progression and suggest that inhibitors of NET formation such as PGE1 and antithrombin can be potential therapeutics to reduce both hypercoagulability and cancer progression." @default.
• W2943562300 created "2019-05-09" @default.
• W2943562300 creator A5002993857 @default.
• W2943562300 creator A5052726478 @default.
• W2943562300 creator A5060716452 @default.
• W2943562300 creator A5063254198 @default.
• W2943562300 creator A5066375463 @default.
• W2943562300 creator A5077647341 @default.
• W2943562300 date "2019-04-29" @default.
• W2943562300 modified "2023-09-30" @default.
• W2943562300 title "Cancer cell–induced neutrophil extracellular traps promote both hypercoagulability and cancer progression" @default.
• W2943562300 cites W1513529801 @default.
• W2943562300 cites W1778191297 @default.
• W2943562300 cites W1917268567 @default.
• W2943562300 cites W1970088110 @default.
• W2943562300 cites W1977521172 @default.
• W2943562300 cites W1998136977 @default.
• W2943562300 cites W2004638361 @default.
• W2943562300 cites W2005700555 @default.
• W2943562300 cites W2034422895 @default.
• W2943562300 cites W2045819100 @default.
• W2943562300 cites W2047432284 @default.
• W2943562300 cites W2050975242 @default.
• W2943562300 cites W2070117107 @default.
• W2943562300 cites W2096054719 @default.
• W2943562300 cites W2104934425 @default.
• W2943562300 cites W2118125488 @default.
• W2943562300 cites W2118217258 @default.
• W2943562300 cites W2121402632 @default.
• W2943562300 cites W2140995313 @default.
• W2943562300 cites W2160351999 @default.
• W2943562300 cites W2166384288 @default.
• W2943562300 cites W2180377648 @default.
• W2943562300 cites W2186799321 @default.
• W2943562300 cites W2237361742 @default.
• W2943562300 cites W2414754150 @default.
• W2943562300 cites W2477245019 @default.
• W2943562300 cites W2523897893 @default.
• W2943562300 cites W2528871059 @default.
• W2943562300 cites W2566525349 @default.
• W2943562300 cites W2567429266 @default.
• W2943562300 cites W2574369735 @default.
• W2943562300 cites W2590321043 @default.
• W2943562300 cites W2662129534 @default.
• W2943562300 cites W2736959940 @default.
• W2943562300 cites W2749725594 @default.
• W2943562300 cites W2751565744 @default.
• W2943562300 cites W2765467375 @default.
• W2943562300 cites W2780198332 @default.
• W2943562300 cites W2800880300 @default.
• W2943562300 cites W2883724795 @default.
• W2943562300 cites W31979510 @default.
• W2943562300 cites W4211005894 @default.
• W2943562300 doi "https://doi.org/10.1371/journal.pone.0216055" @default.
• W2943562300 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6488070" @default.
• W2943562300 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31034495" @default.
• W2943562300 hasPublicationYear "2019" @default.
• W2943562300 type Work @default.
• W2943562300 sameAs 2943562300 @default.
• W2943562300 citedByCount "77" @default.
• W2943562300 countsByYear W29435623002019 @default.
• W2943562300 countsByYear W29435623002020 @default.
• W2943562300 countsByYear W29435623002021 @default.
• W2943562300 countsByYear W29435623002022 @default.
• W2943562300 countsByYear W29435623002023 @default.
• W2943562300 crossrefType "journal-article" @default.
• W2943562300 hasAuthorship W2943562300A5002993857 @default.
• W2943562300 hasAuthorship W2943562300A5052726478 @default.
• W2943562300 hasAuthorship W2943562300A5060716452 @default.
• W2943562300 hasAuthorship W2943562300A5063254198 @default.
• W2943562300 hasAuthorship W2943562300A5066375463 @default.
• W2943562300 hasAuthorship W2943562300A5077647341 @default.
• W2943562300 hasBestOaLocation W29435623001 @default.
• W2943562300 hasConcept C121608353 @default.
• W2943562300 hasConcept C126322002 @default.
• W2943562300 hasConcept C134897094 @default.
• W2943562300 hasConcept C153911025 @default.
• W2943562300 hasConcept C185592680 @default.
• W2943562300 hasConcept C203014093 @default.
• W2943562300 hasConcept C2776914184 @default.
• W2943562300 hasConcept C502942594 @default.
• W2943562300 hasConcept C71924100 @default.
• W2943562300 hasConcept C86803240 @default.
• W2943562300 hasConcept C96232424 @default.
• W2943562300 hasConceptScore W2943562300C121608353 @default.
• W2943562300 hasConceptScore W2943562300C126322002 @default.
• W2943562300 hasConceptScore W2943562300C134897094 @default.
• W2943562300 hasConceptScore W2943562300C153911025 @default.
• W2943562300 hasConceptScore W2943562300C185592680 @default.
• W2943562300 hasConceptScore W2943562300C203014093 @default.
• W2943562300 hasConceptScore W2943562300C2776914184 @default.
• W2943562300 hasConceptScore W2943562300C502942594 @default.
• W2943562300 hasConceptScore W2943562300C71924100 @default.
• W2943562300 hasConceptScore W2943562300C86803240 @default.
• W2943562300 hasConceptScore W2943562300C96232424 @default.
• W2943562300 hasIssue "4" @default.
• W2943562300 hasLocation W29435623001 @default.
• W2943562300 hasLocation W29435623002 @default.

• next